HGR unknown

beautiful thursday

  1. 662 Posts.
    lightbulb Created with Sketch. 217
    This stock will have the big one today. Perfect night in the US. Strong open and continued support expected throughout the day. This one is on the radar after last few days and expect some huge chunks taken out by big players between 5 and 10 cents as they get set long term in the stock. Will go up fast because it is tightly held (Top 20 own 50% of stock - only 380 odd million shares on issue)

    Also, with all the Mexico and potential FDA 510k filing news we have forgotten about the China Deal. That deal is for 1 million units per year rolling order and increasing exponentially. Do you think the Chinese will get a move on after Mexico news and on news of FDA 510k filing coming any day now? My tip is that another 'Mexico like' bonus may be coming soon. It is funny how the perception of people changes after someone else has 'got' something or signed a deal for a new technology or device. It makes others want it too, and the snowball effect could just be the tip of the iceberg with China. Chine will be a nice bonus, but the huge money, it has always been said by the company, is in the US market ( USD $1.3 billion a year market in workplace testing alone)

    Good luck all , and well done to the stayers. I've been in this for more than a year and have stuck by it, always believing there was a huge market for this product, and with drugs being a massive problem in society at present and increasing alarmingly, you need a massive solution.

    I think Brian Andrews and his team have done all the hard work and will reap the rewards along with Mike Fitzpatrick. Well done Andrew Paice (CFO), nice buy of $40000 worth of shares at 1.3 cents (taking his entire holding to 5 million shares - worth a lazy $250k++ now)

    Will be a HUGE day I believe
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.